# Gritstone bio, Inc.

Gritstone bio, Inc. is a company headquartered in Emeryville, CA, United States.

## Company overview

- **Legal name:** Gritstone bio, Inc.
- **Former names in filing history:** Gritstone Oncology, Inc. (2018-05-04 to 2021-04-23)
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Emeryville, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001656634

## About

Gritstone bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001656634, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2024-03-05, it reported annual revenue of USD 16,344,000; net income of USD -138,490,000; total assets of USD 177,769,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $16.3M (USD 16,344,000)
- **Net income:** -$138.5M (USD -138,490,000)
- **Total assets:** $177.8M (USD 177,769,000)
- **Cash and equivalents:** $63.0M (USD 62,986,000)
- **Operating cash flow:** -$121.6M (USD -121,648,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $19.9M (USD 19,945,000)
- **Net income:** -$119.7M (USD -119,687,000)
- **Total assets:** $240.8M (USD 240,754,000)
- **Cash and equivalents:** $55.5M (USD 55,498,000)
- **Operating cash flow:** -$115.9M (USD -115,946,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $48.2M (USD 48,214,000)
- **Net income:** -$75.1M (USD -75,082,000)
- **Total assets:** $278.1M (USD 278,106,000)
- **Cash and equivalents:** $93.3M (USD 93,287,000)
- **Operating cash flow:** -$50.7M (USD -50,678,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $4.0M (USD 4,037,000)
- **Net income:** -$105.3M (USD -105,314,000)
- **Total assets:** $221.6M (USD 221,567,000)
- **Cash and equivalents:** $170.1M (USD 170,056,000)
- **Operating cash flow:** -$89.1M (USD -89,102,000)

## Recent SEC filings

- Form 8-K — filed 2025-04-04 — period 2025-04-03 — 8-K
- Form 8-K — filed 2025-02-25 — period 2025-02-14 — 8-K
- Form 8-K — filed 2025-02-14 — period 2025-01-14 — 8-K
- Form 8-K — filed 2025-01-03 — period 2024-12-30 — 8-K
- Form 8-K — filed 2024-12-13 — period 2024-12-09 — 8-K
- Form 8-K — filed 2024-11-29 — period 2024-11-27 — 8-K
- Form 8-K — filed 2024-11-15 — period 2024-11-13 — 8-K
- Form 8-K — filed 2024-10-16 — period 2024-10-11 — 8-K
- Form 8-K — filed 2024-10-10 — period 2024-10-10 — 8-K
- Form SC 13G — filed 2024-10-07 — SC 13G
- Form 8-K — filed 2024-10-01 — period 2024-09-30 — 8-K
- Form 10-Q — filed 2024-08-13 — period 2024-06-30 — 10-Q

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/gritstone-bio-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology